1. Home
  2. CACI vs HALO Comparison

CACI vs HALO Comparison

Compare CACI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CACI International Inc.

CACI

CACI International Inc.

HOLD

Current Price

$541.71

Market Cap

12.9B

Sector

Technology

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$68.88

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACI
HALO
Founded
1962
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.9B
7.4B
IPO Year
1979
N/A

Fundamental Metrics

Financial Performance
Metric
CACI
HALO
Price
$541.71
$68.88
Analyst Decision
Buy
Buy
Analyst Count
14
12
Target Price
$616.50
$73.33
AVG Volume (30 Days)
256.3K
2.3M
Earning Date
01-21-2026
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
12.06
56.68
EPS
22.62
4.74
Revenue
$8,858,558,000.00
$1,242,852,000.00
Revenue This Year
$10.72
$34.83
Revenue Next Year
$6.19
$24.84
P/E Ratio
$23.96
$14.54
Revenue Growth
12.61
31.19
52 Week Low
$318.60
$47.00
52 Week High
$632.77
$79.50

Technical Indicators

Market Signals
Indicator
CACI
HALO
Relative Strength Index (RSI) 32.41 58.75
Support Level $538.10 $61.23
Resistance Level $563.00 $69.28
Average True Range (ATR) 12.90 1.69
MACD -5.46 0.69
Stochastic Oscillator 6.03 93.54

Price Performance

Historical Comparison
CACI
HALO

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: